Iradimed (IRMD) Retained Earnings (2013 - 2026)

Iradimed (IRMD) has 14 years of Retained Earnings data on file, last reported at $31.0 million in Q1 2026.

• On a quarterly basis, Retained Earnings fell 47.7% year-over-year to $31.0 million in Q1 2026; TTM through Mar 2026 was $31.0 million, a 47.7% decrease from a year earlier, with the FY2025 full-year figure at $30.4 million, down 46.5% from the prior year.
• Retained Earnings for Q1 2026 stood at $31.0 million, up from $30.4 million in the prior quarter.
• Over the last five years, Retained Earnings for IRMD reached as high as $59.3 million in Q1 2025 and fell as low as $6127.0 in Q1 2022.
• Historically, Retained Earnings has averaged $35.0 million across 5 years, with a median of $31.0 million in 2026.
• Across the five-year window, Retained Earnings tumbled 80.98% in 2022 and jumped 438796.88% in 2023, its largest moves.
• Year by year, Retained Earnings stood at $26.4 million in 2022, then surged by 63.81% to $43.3 million in 2023, then jumped by 31.28% to $56.8 million in 2024, then plunged by 46.5% to $30.4 million in 2025, then increased by 2.09% to $31.0 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $31.0 million in Q1 2026, $30.4 million in Q4 2025, and $32.0 million in Q3 2025.